Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia.
The prevalence of obesity in the pediatric population has increased in the last 2 decades and represents a serious health concern, with potential impact on outcomes of hematopoietic cell transplantation (HCT). We studied the effect of weight by age-adjusted body mass index (BMI) percentile in 1,281 pediatric patients (age 2-19 years) with severe aplastic anemia who underwent HCT between 1990 and 2005. The study population was divided into 5 weight groups-underweight, risk of underweight, normal BMI range, risk of overweight, and overweight-according to age-adjusted BMI percentiles. Cox proportional hazards regression models for survival and acute graft-versus-host disease (aGVHD), performed using weight groups as the main effect and the normal BMI range (26th-75th percentile) as the baseline comparison, found higher mortality among overweight children (>95th percentile adjusted for age). Weight at transplantation did not increase the adjusted risk of grade III-IV aGVHD. The 1-year and 2-year overall survival rates were 60% and 59% for overweight children, compared with >70% in children with lower BMI at both time points (P < .001). Other significant factors associated with survival included race and region, donor type, conditioning regimens in related donor transplants, performance score, and year of transplantation. In conclusion, overweight children with aplastic anemia have worse outcomes after HCT. The impact of obesity on survival outcomes in children should be discussed during pretransplantation counseling.
Barker
Collin C
CC
British Colombia Children's Hospital, Vancouver, British Columbia, Canada.
Agovi
Manza-A
MA
Logan
Brent
B
Lazarus
Hillard M
HM
Ballen
Karen K
KK
Gupta
Vikas
V
Hale
Gregory A
GA
Frangoul
Haydar
H
Ho
Vincent
V
Rizzo
J Douglas
JD
Pasquini
Marcelo C
MC
D000293:Adolescent; D000741:Anemia, Aplastic / Q000150:complications* / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D015992:Body Mass Index; D016026:Bone Marrow Transplantation / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D005260:Female; D006086:Graft vs Host Disease / Q000150:complications* / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D015999:Multivariate Analysis; D009765:Obesity / Q000150:complications* / Q000401:mortality / Q000503:physiopathology; D044469:Racial Groups; D012189:Retrospective Studies; D012720:Severity of Illness Index; D015996:Survival Rate; D013851:Thinness / Q000150:complications* / Q000401:mortality / Q000503:physiopathology; D016896:Treatment Outcome; D055815:Young Adult
Bone Marrow Transplant. 2000 Dec;26(11):1185-91
11149729
Int J Pediatr Obes. 2006;1(1):26-32
17902212
Biol Blood Marrow Transplant. 2006 Aug;12(8):876-84
16864058
Am J Med. 1997 Mar;102(3):265-8
9217595
JAMA. 2005 Jan 12;293(2):203-11
15644547
Biol Blood Marrow Transplant. 2010 Oct;16(10):1442-50
20412867
Blood. 2005 Oct 15;106(8):2912-9
15994282
Biol Blood Marrow Transplant. 2006 May;12(5):541-51
16635789
Transplantation. 1974 Oct;18(4):295-304
4153799
Br J Haematol. 2005 Sep;130(5):747-51
16115132
Bone Marrow Transplant. 2001 Aug;28(4):365-7
11571508
Pediatrics. 2002 Jan;109(1):45-60
11773541
Biol Blood Marrow Transplant. 2009 Jan;15(1):73-82
19135945
J Pediatr. 1998 Feb;132(2):204-10
9506629
JAMA. 2008 May 28;299(20):2401-5
18505949
Br J Haematol. 2008 Jan;140(2):214-7
18028482
Am J Clin Nutr. 2002 Jun;75(6):978-85
12036802
Biol Blood Marrow Transplant. 2008 Jul;14(7):748-58
18541193
J Clin Oncol. 2007 May 20;25(15):2063-9
17513811